Eye News and Research

Latest Eye News and Research

New technique developed to transform regular body cells into artificial stem cells

Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in STEM CELLS, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.

23 Oct 2009

OIS EyeScan and OIS Symphony Digital Reporter systems to feature at AAO Annual Meeting

Ophthalmic Imaging Systems ("OIS" or "the Company") (OTCBB: OISI), a leading digital imaging and informatics company, today announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions at the American Academy of Ophthalmology's (AAO) 113th Annual Meeting, being held October 24 - 27, 2009, at the Moscone Convention Center in San Francisco, CA.

23 Oct 2009

Researchers discover neurons that precisely keep time in the primate brain

Groups of neurons that precisely keep time have been discovered in the primate brain by a team of researchers that includes Dezhe Jin, assistant professor of physics at Penn State University and two neuroscientists from the RIKEN Brain Science Institute in Japan and the Massachusetts Institute of Technology (MIT).

23 Oct 2009

Report: Quality of care for insured Americans slipped in 2008

CNNMoney reports that for the first time in more than 10 years, the "overall quality of health care" for Americans insured through commercial and public plans appears to have slipped.

23 Oct 2009

Ellex Medical Lasers to launch latest version of Eye Cubed diagnostic ultrasound system

Ellex Medical Lasers Limited, a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, today announced that it will introduce the latest version of the Eye Cubed(TM) diagnostic ultrasound system at the annual meeting of the American Academy of Ophthalmology (AAO), October 24 - 27, 2009 in San Francisco.

23 Oct 2009

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.

22 Oct 2009

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

Mead Johnson Nutrition Company announced today its financial results for the third quarter ended Sept. 30, 2009.

22 Oct 2009

Cosmetic procedures for a competitive edge in the workplace

As the unemployment numbers heat up, so does the competition for available jobs. To get an edge, increasing numbers of job seekers are looking to cosmetic procedures to give them confidence and a competitive edge in the workplace. Indeed, a recent survey released by The American Society of Plastic Surgeons (ASPS) supports this.

22 Oct 2009

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

ISTA Pharmaceuticals, Inc. today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.

22 Oct 2009

GeckoSystems to discuss its sensor fusion based vision system

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) -- announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' sensor fusion based vision system, the CompoundSensorArray™.

22 Oct 2009

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

Tissue Banks International (TBI) has announced the availability of the VisionGraft Sterile Cornea, the nation's first sterile cornea allograft. The VisionGraft Sterile Cornea (patent pending) is an irradiated cornea for use in tectonic transplant procedures.

22 Oct 2009

Electronic eye implant mimics human retina; restores partial vision

A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. A team led by Dr. Lucian V. Del Priore at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the June 26 surgery -- the first case of its kind in New York.

22 Oct 2009

White House offer on malpractice finds takers; Obama tells Dems to 'focus'

Since President Obama proposed using $25 million to test new ways to handle malpractice lawsuits, suitors have been lining up, the The Asssociated Press reports. One leading idea is to appoint expert panels to sort fact from fiction in malpractice claims.

22 Oct 2009

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced upcoming scientific and corporate presentations on its implantable telescope technology.

21 Oct 2009

Certain molecules found to play an important role in regulating circadian rhythm: Study

Molecules that may hold the key to new ways to fight cancer and other diseases have been found to play an important role in regulating circadian rhythm, says Liheng Shi, a researcher in Texas A&M's Department of Veterinary Integrative Biosciences.

21 Oct 2009

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company’s experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.

21 Oct 2009

Auxano point-of-care indicator system for dry eye syndrome

Auxano Diagnostics, LLC, a subsidiary of Auxano Biomedical, LLC, has announced the application of the company’s breakthrough wound care technology to the treatment of dry eye syndrome (DES) with the Auxano point-of-care indicator system.

21 Oct 2009

FDA grants Fast Track designation for MacuSight's Perceiva

MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).

21 Oct 2009

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the proprietary technologies of each.

21 Oct 2009

First Edition: October 21, 2009

As Senate Democrats wrestle with a doctor payment bill separate from sweeping health care reform proposals, the public plan, public opinion and health care costs continue to be a Capitol Hill focus.

21 Oct 2009

Eye News and Research

Latest Eye News and Research

New technique developed to transform regular body cells into artificial stem cells

OIS EyeScan and OIS Symphony Digital Reporter systems to feature at AAO Annual Meeting

Researchers discover neurons that precisely keep time in the primate brain

Report: Quality of care for insured Americans slipped in 2008

Ellex Medical Lasers to launch latest version of Eye Cubed diagnostic ultrasound system

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

Cosmetic procedures for a competitive edge in the workplace

ISTA Pharmaceuticals' presentations on Phase 3 clinical results of Bepreve

GeckoSystems to discuss its sensor fusion based vision system

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

Electronic eye implant mimics human retina; restores partial vision

White House offer on malpractice finds takers; Obama tells Dems to 'focus'

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

Certain molecules found to play an important role in regulating circadian rhythm: Study

Lux Biosciences to present on LX211 at 2009 AAO annual conference

Auxano point-of-care indicator system for dry eye syndrome

FDA grants Fast Track designation for MacuSight's Perceiva

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

First Edition: October 21, 2009

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Eye News and Research

Latest Eye News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in